Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 3/20 | 0.46 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.44 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.39 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31360271 | 1.00 | ALOX5AP (0.46) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL25156064 | 1.00 | ALOX5AP (0.46) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL31360002 | 0.97 | ALOX5AP (0.49) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL31360230 | 0.97 | ALOX5AP (0.49) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL25155629 | 0.97 | ALOX5AP (0.49) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL25155585 | 0.97 | ALOX5AP (0.49) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL31360077 | 0.97 | ALOX5AP (0.49) | ALOX5APGPR119CHEK2LMNANPSR1 | |
| SCHEMBL25156353 | 0.93 | ALOX5AP (0.43) | ALOX5APGPR119LMNANPSR1FEN1 | |
| SCHEMBL25155387 | 0.93 | ALOX5AP (0.43) | ALOX5APGPR119LMNANPSR1FEN1 | |
| SCHEMBL31360281 | 0.93 | ALOX5AP (0.43) | ALOX5APGPR119LMNANPSR1FEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | Clear Creek Bio, Inc. (US) | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250025443-A1 | COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES | ACE, PREP, PEPD | ALOX5AP 456/4885GPR119 3277/4885CHEK2 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.